Skip to content Skip to footer
Subscribe Now

VIEWPOINTS

Viewpoints_Meghan Scanlon
PharmaShots Interview: Boston Scientific’s Meghan Scanlon Shares Insight on the Completion of its $1.07B Lumenis Acquisition
In an interview with PharmaShots, Meghan Scanlon, Senior Vice President and President for Urology and Pelvic Health at Boston Scientific shares her views on the completion of its $1.07B  acquisition of Lumenis surgical business Shots: Boston Scientific reported the closing of its acquisition of the Lumenis surgical business from a BPEA affiliate for an upfront of $1.07B. The acquisition follows the Mar…
December 20, 2021
Viewpoints_Thierry Abribat
PharmaShots Interview: Amolyt Pharma’s Thierry Abribat Shares Insight on the Data of AZP-3601 for Hypoparathyroidism
In an interview with PharmaShots, Thierry Abribat, Founder and Chief Executive Officer at Amolyt Pharma shares his views on the data from the P-I trial of AZP-3601 for the treatment of Hypoparathyroidism Shots: The P-I trial evaluates the safety, tolerability, PK, PD, and preliminary efficacy of AZP-3601 in 102 healthy volunteers including 52 in the SAD and 50 in the MAD cohorts…
December 15, 2021
Viewpoints_Neil Moat
PharmaShots Interview: Abbott’s Neil Moat Shares Insight on the US FDA’s Approval of Epic Plus Tissue Valves for Mitral or Aortic Valve Replacement
In an interview with PharmaShots, Neil Moat, MD, DVP Medical Affairs, Chief Medical Officer at Abbott's shares his views on the Epic Plus Tissue Valves approval for the treatment of mitral or aortic valve replacement The US FDA has approved Epic Plus & Epic Plus Supra Stented Tissue Valves to improve therapy options for patients with aortic or mitral valve…
December 14, 2021
Viewpoints_Alexander Bedenkov
PharmaShots Interview: AstraZeneca’s Alexander Bedenkov Shares Insight on First Virtual Events with Slush to Improve Patients Outcomes
In an interview with PharmaShots, Alexander Bedenkov, Vice President, Medical International Region & Global Health Innovation Hubs (A.Catalyst) Network Head at AstraZeneca shares his views on the First Virtual Events in collaboration with Slush to accelerate better health outcomes through innovation Shots: The companies collaborated to launch virtual events and enhance collaboration in the healthcare sector. The event was run through AstraZeneca’s A.Catalyst Network,…
December 13, 2021
Viewpoints_Manos Perros
PharmaShots Interview: Entasis Therapeutics’s Manos Perros Shares Insight on the Data of Sulbactam-Durlobactam (SUL-DUR) for Carbapenem-Resistant Acinetobacter Infections
In an interview with PharmaShots, Manos Perros shares his views on the data from the P-III (ATTACK) trial of sulbactam-durlobactam (SUL-DUR) for carbapenem-resistant acinetobacter infections Shots: The P-III ATTACK trial evaluates SUL-DUR vs colistin in 207 patients with infections caused by Acinetobacter baumannii at 95 clinical sites in 17 countries The trial met its 1EPs i.e., patients achieved non-inferiority in 28-day all-cause…
December 9, 2021
Viewpoints_Glenn Mattes
PharmaShots Interview: TFF Pharmaceuticals’s Glenn Mattes Shares Insights on the Thin Film Freezing Technology
In an interview with PharmaShots, Glenn Mattes, President, CEO, and Director at TFF Pharmaceuticals share his views on the thin film freezing technology for the development of vaccines and therapeutics against multiple infectious diseases including IPA Shots: The company focuses on developing and commercializing innovative drug products based on its patented TFF technology platform including the development of vaccines and therapeutics against multiple infectious…
December 8, 2021
Viewpoints_Atray Dixit
PharmaShots Interview: Coral Genomics’s Atray Dixit Shares Insights on the 2021 Innovation Challenge in Inflammatory Bowel Disease
In an interview with PharmaShots, Atray Dixit, Co-founder & CEO at Coral Genomics share his views on the winner of the $25K inflammatory bowel disease innovation challenge under the collaboration with Lyfebulb and Arena Shots: Lyfebulb and Arena collaborated to discover 2021 Imagining Life Without Limits Challenge to get the solutions for patients with IBD Coral Genomics was selected as…
December 7, 2021
Viewpoints_Ben Schlatka
PharmaShots Interview: Medidata’s Ben Schlatka Shares Insights on Agreement with Labcorp to Advance the Use of Medical-Grade Sensors
In an interview with PharmaShots, Ben Schlatka, Vice President, Digital Biomarker Solutions at Medidata share his views on the Agreement with Labcorp to expand decentralized clinical trial capabilities and digital biomarker discovery using Medidata Sensor Cloud Shots: The companies collaborated to advance the use of medical-grade sensors & accelerate biomarker discovery in clinical research including an at-home version of 6MWT…
December 6, 2021
Viewpoints_Dr. Murat Kalayoglu
PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease
In an interview with PharmaShots, Dr. Murat Kalayoglu, MD, Ph.D., President, and Chief Executive Officer at Cartesian Therapeutics shared his insights on the P-I/IIa study of Descartes-08 for the treatment of the chronic autoimmune disorder generalized myasthenia gravis (gMG) Shots: Descartes-08 is an autologous T-cell product that is engineered with RNA to encode for CAR The company focuses to use…
December 1, 2021
Viewpoints_Mark Becker
PharmaShots Interview: Vivacare’s Mark Becker Shares Insight on the Digital Patient Education Service for Allergic Conditions
In an interview with PharmaShots, Mark Becker, MD, founder, President, and CEO at Vivacare shared his views on the new collaboration with Asthma and Allergy Network to provide a Digital patient education service for allergic conditions Shots: Vivacare and the AAN collaborated to develop a digital patient education service for members regarding allergies, asthma, eczema, and…
November 30, 2021
Load more